Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

2012 ◽  
Vol 72 (6) ◽  
pp. 851-857 ◽  
Author(s):  
Marjatta Leirisalo-Repo ◽  
Hannu Kautiainen ◽  
Leena Laasonen ◽  
Markku Korpela ◽  
Markku J Kauppi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Combination Therapy ◽  
Early Rheumatoid Arthritis ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

A randomized, double-blind, placebo-controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

1995 ◽  
Vol 38 (8) ◽  
pp. 1097-1106 ◽  
Author(s):  
Peter A. Van Der Lubbe ◽  
Ben A. C. Dijkmans ◽  
Hendrik M. Markusse ◽  
Ulla Nässander ◽  
Ferdinand C. Breedveld
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Early Rheumatoid Arthritis ◽  
Antibody Therapy ◽  
Controlled Study ◽  
Monoclonal Antibody Therapy ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study

PLoS ONE ◽  
2017 ◽  
Vol 12 (6) ◽  
pp. e0178463 ◽  
Author(s):  
Ilaria Buondonno ◽  
Guido Rovera ◽  
Francesca Sassi ◽  
Micol Maria Rigoni ◽  
Claudia Lomater ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Vitamin D ◽  
Early Rheumatoid Arthritis ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

IX 207-887 in Rheumatoid Arthritis. A double-blind placebo-controlled study

1992 ◽  
Vol 35 (9) ◽  
pp. 999-1006 ◽  
Author(s):  
Maxime Dougados ◽  
Bernard Combe ◽  
Thomas Beveridge ◽  
Isabelle Bourdeix ◽  
Anne Lallemand ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document